Ad4-H5-Vtn (Emergent BioSolutions/National Institute of Allergy and Infectious Diseases)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameAd4-H5-Vtn (Emergent BioSolutions/National Institute of Allergy and Infectious Diseases)
Drug Alias NameAd4-H5-Vtn (National Institute of Allergy and Infectious Diseases)
ClassificationVaccines > Development/production technology > Live attenuated vaccineVaccines > Development/production technology > Recombinant vector vaccine
Mechanisms of ActionInfluenza virus hemagglutinin glycoproteins modulators
TargetsInfluenza virus hemagglutinin glycoproteins
Therapy Area/IndicationsCommunicable Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesEmergent Biosolutions Inc
China Registration ClassN/A

Develop Information

Active CompaniesEmergent Biosolutions IncNational Institute Of Allergy And Infectious Diseases (Niaid)
Inactive CompaniesN/A
Active IndicationsCommunicable Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A